Influence of intravenous iron therapy on novel markers of iron deficiency

International Journal of Artificial Organs

Volumn 33, Issue 5, 2010, Pages 297-301

  Chinnappa, Shanmugakumar ^a   Bhandari, Sunil ^a  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Anemia; Chronic kidney disease; Dialysis; Erythropoietin stimulating agent

Indexed keywords

DISEASE CONTROL; IRON; PATIENT TREATMENT;

ANEMIA; BACKGROUND DETECTION; CHRONIC KIDNEY DISEASE; END-STAGE RENAL DISEASE; END-STAGE RENAL DISEASE PATIENTS; ERYTHROPOIETIN STIMULATING AGENT; INTRAVENOUS IRON; IRON DEFICIENCY; MEAN AGES; PROSPECTIVES;

DIALYSIS;

FERRIC HYDROXIDE SUCROSE; FERRITIN; IRON; TRANSFERRIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; IRON DEFICIENCY; IRON THERAPY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RETICULOCYTE; TRANSFERRIN BLOOD LEVEL;

EID: 77954646799     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300505     Document Type: Article

References (21)

1. Bhandari S, Brownjohn AM, Turney JH. Response of mean reticulocyte haemoglobin content to intravenous iron therapy in haemodialysis patients. Nephrol Dial Transplant 1998; 13 :3276-7. (Pubitemid 28534759)
2. Bhandari S, Turney JH, Brownjohn AM, Norfolk D. Reticulocyte indices in patients with end stage renal disease on hemodialysis. J Nephrol 1998; 11: 78-82. (Pubitemid 28206793)
3. Bhandari S, Norfolk D, Brownjohn A, Turney J. Novel haematological parameters in patients receiving recombinant human erythropoietin and undergoing haemodialysis. Hematology 1998; 3: 67-75. (Pubitemid 28499690)
4. Schaefer RM, Schaefer L. Hypochromic red blood cells and reticulocytes. Kidney Int Suppl 1999; 69: S44-8.
5. Brugnara C, Colella GM, Cremins J, et al. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med 1994; 123: 660-7.
6. Bhandari S, Norfolk D, Brownjohn A, Turney J. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy. Am J Kidney Dis 1997; 30: 814-21.
7. Briggs C, Rogers R, Thompson B. New red cell parameters on the Sysmex XE-2100 TM as potential markers of functional iron deficiency. Transfus Med Hemother 2001; 28: 256-62.
8. Lacombe F, Lacoste L, Vial JP, et al. Automated reticulocyte counting and immature reticulocyte fraction measurement. Comparison of ABX PENTRA 120 Retic, Sysmex R-2000, flow cytometry, and manual counts. Am J Clin Pathol 1999; 112: 677-86. (Pubitemid 30214758)
9. Schimenti KJ, Lacerna K, Wamble A, et al. Reticulocyte quantification by flow cytometry, image analysis, and manual counting. Cytometry 1992; 13: 853-62.
10. Briggs C, D G, Machin SJ. Comparison of the automated reticulocyte counts and immature reticulocyte fraction measurements obtained with ABX Pentra 120 Retic Blood Analyzer and Sysmex XE-2100 Automated Hematology Analyzer. Lab Hematol 2001; 7: 75-80. (Pubitemid 32707688)
11. Valderrabano F, Horl WH, Jacobs C, et al. European best practice guidelines 1-4: evaluating anaemia and initiating treatment. Nephrol Dial Transplant 2000;15 (Suppl 4): S8-14.
12. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-11. (Pubitemid 33070486)
13. Kim JM, Ihm CH, Kim HJ. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients. Int J Lab Hematol 2008; 30: 46-52.
14. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006; 1 (Suppl 1): S4-8.
15. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006; 28: 303-8. (Pubitemid 44453675)
16. Tessitore N, Solero GP, Lippi G, et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 2001; 16: 1416-23.
17. Singh AK, Coyne DW, Shapiro W, Rizkala AR. Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation. Kidney Int 2007; 71: 1163-71. (Pubitemid 46809141)
18. Schaefer L, Schaefer RM. A primer on iron therapy. Nephrol Dial Transplant 2007; 22: 2429-31.
19. Bovy C, Gothot A, Delanaye P, Warling X, Krzesinski JM, Beguin Y. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrol Dial Transplant 2007; 22: 1156-62. (Pubitemid 46523432)
20. Eschbach JW, Cook JD. Quantitating iron balance in hemodialysis patients. Trans Am Soc Artif Intern Organs 1977; 23: 54-8.
21. Eschbach JW, Cook JD, Scribner BH, Finch CA. Iron balance in hemodialysis patients. Ann Intern Med 1977; 87: 710-3.